# Petmed Express Inc: Form 10-Q for the period ended Dec 31, 2016

- Company: [Petmed Express Inc](/companies/pets.md) (CIK 1040130)
- Form: 10-Q
- Filed: 2017-01-31
- Accepted by EDGAR: Jan 31, 2017, 12:07 ET
- Period: 2016-12-31
- Accession: 0001571049-17-000891
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1040130/000157104917000891/t1700052_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1040130/000157104917000891/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2016-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 9 months, 2016-04-01 to 2016-12-31 | $186.1m | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months, 2016-10-01 to 2016-12-31 | $36.2m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months, 2016-04-01 to 2016-12-31 | $129.0m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2016-10-01 to 2016-12-31 | $16.6m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2016-04-01 to 2016-12-31 | $57.2m | us-gaap:GrossProfit |
| Operating income | 3 months, 2016-10-01 to 2016-12-31 | $7.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2016-04-01 to 2016-12-31 | $25.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2016-10-01 to 2016-12-31 | $3.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2016-04-01 to 2016-12-31 | $9.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2016-10-01 to 2016-12-31 | $4.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2016-04-01 to 2016-12-31 | $16.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2016-10-01 to 2016-12-31 | $0.24 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2016-04-01 to 2016-12-31 | $0.80 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2016-10-01 to 2016-12-31 | $0.24 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2016-04-01 to 2016-12-31 | $0.81 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2016-10-01 to 2016-12-31 | 20,408 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2016-04-01 to 2016-12-31 | 20,373 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 9 months, 2016-04-01 to 2016-12-31 | $9.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2016-04-01 to 2016-12-31 | $11.6m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | at 2016-12-31 | $47.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2016-12-31 | $67.7m | us-gaap:AssetsCurrent |
| Total assets | at 2016-12-31 | $97.6m | us-gaap:Assets |
| Current liabilities | at 2016-12-31 | $7.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2016-12-31 | $8.2m | us-gaap:Liabilities |
| Shareholders' equity | at 2016-12-31 | $89.4m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 21,458 characters.

### Executive Summary

PetMed Express was incorporated in the state of Florida in January 1996. The Company’s common stock is traded on the NASDAQ Global Select Market under the symbol “PETS.” The Company began selling pet medications and other pet health products in September 1996. In March 2010 the Company started offering for sale additional pet supplies on its website, and these items are drop shipped to customers by third party vendors. Presently, the Company’s product line includes approximately 3,000 of the most popular pet medications, health products, and supplies for dogs and cats.

The Company markets its products through national advertising campaigns which aim to increase the recognition of the “1-800-PetMeds” brand name, and “PetMeds” family of trademarks, increase traffic on its website at www.1800petmeds.com, acquire new customers, and maximize repeat purchases. Approximately 83% of all sales were generated via the Internet for the quarter ended December 31, 2016, compared to 81% for the quarter ended December 31, 2015. The Company’s sales consist of products sold mainly to retail consumers. The three-month average purchase was approximately $81 and $78 per order for the quarters ended December 31, 2016 and 2015, respectively, and the nine-month average purchase was approximately $82 and $80 per order for the periods ended December 31, 2016 and 2015, respectively.

Critical Accounting Policies

Our discussion and analysis of our financial condition and the results of our operations are based upon our Condensed Consolidated Financial Statements and the data used to prepare them. The Company’s Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America. On an ongoing basis we re-evaluate our judgments and estimates including those related to product returns, bad debts, inventories, and income taxes. We base our estimates and judgments on our historical experience, knowledge of current conditions, and our beliefs of what could occur in the future considering available information. Actual results may differ from these estimates under different assumptions or conditions. Our estimates are guided by observing the following critical accounting policies.

Revenue recognition

The Company generates revenue by selling pet medication products and pet supplies primarily to retail consumers. The Company’s policy is to recognize revenue from product sales upon shipment, when the rights of ownership and risk of loss have passed to the customer. Outbound shipping and handling fees are included in sales and are billed upon shipment. Shipping expenses are included in cost of sales. The majority of the Company’s sales are paid by credit cards and the Company usually receives the cash settlement in two to three banking days. Credit card sales minimize accounts receivable balances relative to sales. The Company maintains an allowance for doubtful accounts for losses that the Company estimates will arise from customers’ inability to make required payments, arising from either credit card charge-backs or insufficient funds checks. The Company determines its estimates of the uncollectibility of accounts receivable by analyzing historical bad debts and current economic trends. The allowance for doubtful accounts was approximately $12,000 at December 31, 2016 compared to $13,000 at March 31, 2016.

Valuation of inventory

Inventories consist of prescription and non-prescription pet medications and pet supplies that are available for sale and are priced at the lower of cost or market value using a weighted average cost method. The Company writes down its inventory for estimated obsolescence. The inventory reserve was approximately $37,000 at December 31, 2016 compared to $64,000 at March 31, 2016.

Advertising

The Company's advertising expense consists primarily of Internet marketing and direct mail/print advertising. Internet costs are expensed in the month incurred and direct mail/print advertising costs are expensed when the related catalogs, brochures, and postcards are produced, distributed, or superseded.

Accounting for income taxes

The Company accounts for income taxes under the provisions of ASC Topic 740 (“*Accounting for Income Taxes”*), which generally requires recognition of deferred tax assets and liabilities for the expected future tax benefits or consequences of events that have been included in the Consolidated Financial Statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting carrying values and the tax bases of assets and liabilities, and are measured by applying enacted tax rates and laws for the taxable years in which those differences are expected to reverse.

### Results of Operations

The following should be read in conjunction with the Company’s Condensed Consolidated Financial Statements and the related notes thereto included elsewhere herein. The following table sets forth, as a percentage of sales, certain operating data appearing in the Company’s Condensed Consolidated Statements of Comprehensive Income:

|  | Three Months Ended December 31, 2016 | 2015 | Nine Months Ended December 31, 2016 | 2015 |
| --- | ---: | ---: | ---: | ---: |
| Sales | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of sales | 68.5 | 67.1 | 69.3 | 67.3 |
| Gross profit | 31.5 | 32.9 | 30.7 | 32.7 |
| Operating expenses: |  |  |  |  |
| General and administrative | 10.1 | 9.8 | 9.2 | 9.0 |
| Advertising | 6.0 | 7.8 | 7.2 | 10.1 |
| Depreciation | 0.9 | 0.3 | 0.5 | 0.3 |
| Total operating expenses | 17.0 | 17.9 | 16.9 | 19.4 |
| Income from operations | 14.5 | 15.0 | 13.8 | 13.3 |
| Total other income | 0.3 | 0.1 | 0.2 | 0.1 |
| Income before provision for income taxes | 14.8 | 15.1 | 14.0 | 13.4 |
| Provision for income taxes | 5.7 | 5.5 | 5.2 | 4.9 |
| Net income | 9.1% | 9.6% | 8.8% | 8.5% |

9

**Three Months Ended December 31, 2016 Compared With Three Months Ended December 31, 2015, and Nine Months Ended December 31, 2016 Compared With Nine Months Ended December 31, 2015**

### Sales

Sales increased by approximately $1.9 million, or 3.8%, to approximately $52.9 million for the quarter ended December 31, 2016, from approximately $50.9 million for the quarter ended December 31, 2015. For the nine months ended December 31, 2016, sales increased by approximately $6.9 million, or 3.8%, to approximately $186.1 million compared to $179.3 million for the nine months ended December 31, 2015. The increase in sales for the three and nine months ended December 31, 2016 was primarily due to increased new order and reorder sales. The Company acquired approximately 99,000 new customers for the quarter ended December 31, 2016 compared to approximately 98,000 new customers for the same period the prior year. For the nine months ended December 31, 2016 the Company acquired approximately 388,000 new customers, compared to 374,000 new customers for the nine months ended December 31, 2015. The following chart illustrates sales by various sales classifications:

|  | Three Months Ended December 31, |  |  |  |
| --- | ---: | ---: | ---: | ---: |
| **Sales (In thousands)** | **2016%** | **2015%** | **$ Variance** | **% Variance** |
| Reorder Sales | $44,937 85.0% | $43,338 85.1% | $1,599 | 3.7% |
| New Order Sales | $7,929 15.0% | $7,595 14.9% | $334 | 4.4% |
| Total Net Sales | $52,866 100.0% | $50,933 100.0% | $1,933 | 3.8% |
| Internet Sales | $43,772 82.8% | $41,461 81.4% | $2,311 | 5.6% |
| Contact Center Sales | $9,094 17.2% | $9,472 18.6% | $(378) | -4.0% |
| Total Net Sales | $52,866 100.0% | $50,933 100.0% | $1,933 | 3.8% |

|  | Nine Months Ended December 31, |  |  |  |
| --- | ---: | ---: | ---: | ---: |
| **Sales (In thousands)** | **2016%** | **2015%** | **$ Variance** | **% Variance** |
| Reorder Sales | $154,202 82.8% | $149,550 83.4% | $4,652 | 3.1% |
| New Order Sales | $31,942 17.2% | $29,742 16.6% | $2,200 | 7.4% |
| Total Net Sales | $186,144 100.0% | $179,292 100.0% | $6,852 | 3.8% |
| Internet Sales | $153,161 82.3% | $145,315 81.0% | $7,846 | 5.4% |
| Contact Center Sales | $32,983 17.7% | $33,977 19.0% | $(994) | -2.9% |
| Total Net Sales | $186,144 100.0% | $179,292 100.0% | $6,852 | 3.8% |

Going forward sales may be adversely affected due to increased competition and consumers giving more consideration to price. No guarantees can be made that sales will grow in the future. The majority of our product sales are affected by the seasons, due to the seasonality of mainly heartworm, and flea and tick medications. For the quarters ended June 30, September 30, December 31, and March 31 of Fiscal 2016, the Company’s sales were approximately 30%, 24%, 22%, and 24%, respectively.

### Cost of sales

Cost of sales increased by approximately $2.0 million, or 6.0%, to approximately $36.2 million for the quarter ended December 31, 2016, from approximately $34.2 million for the quarter ended December 31, 2015. For the nine months ended December 31, 2016, cost of sales increased by approximately $8.3 million, or 6.9%, to approximately $129.0 million compared to $120.7 million for the same period in the prior year. The increase in cost of sales is directly related to the increase in sales during the quarter and nine months ended December 31, 2016. Cost of sales as a percent of sales was 68.5% and 67.1% for the quarters ended December 31, 2016 and 2015, respectively, and for the nine months ended December 31, 2016 and 2015 the cost of sales was 69.3% and 67.3%, respectively. The increases to cost of sales as a percentage of sales for the quarter and nine months ended December 31, 2016 can be mainly attributed to an increase in product costs on certain brands and additional discounts given to customers to increase sales during the quarter and nine months.

### Gross profit

Gross profit decreased by approximately $111,000 to approximately $16.6 million for the quarter ended December 31, 2016, from approximately $16.8 million for the quarter ended December 31, 2015. For the nine months ended December 31, 2016 gross profit decreased by approximately $1.5 million, or 2.5%, to approximately $57.2 million, compared to $58.6 million for the same period in the prior year. Gross profit as a percentage of sales was 31.5% and 32.9% for the three months ended December 31, 2016 and 2015, respectively, and for the nine months ended December 31, 2016 and 2015, gross profit was 30.7% and 32.7%, respectively. The gross profit percentage decreases for the quarter and nine months ended December 31, 2016 can be mainly attributed to an increase in product costs on certain brands and additional discounts given to customers to increase sales during the quarter and nine months ended December 31, 2016.

### General and administrative expenses

General and administrative expenses increased by approximately $384,000, or 7.7%, to approximately $5.4 million for the quarter ended December 31, 2016, from approximately $5.0 million for the quarter ended December 31, 2015. The increase in general and administrative expenses for the quarter ended December 31, 2016 was primarily due to the following: a $342,000 increase in payroll expenses related to increased stock compensation expense and additional expenses related to the move of the corporate headquarters; a $39,000 increase in bank service fees; a $29,000 increase in telephone expenses; and a $29,000 increase in other expenses which included office expenses and professional fees. Offsetting the increase was a decrease to property expenses of $38,000 and a $17,000 decrease to other expenses which primarily included licenses and insurance expenses.

For the nine months ended December 31, 2016, general and administrative expenses increased by approximately $1.0 million, or 6.4%, to approximately $17.2 million, compared to $16.2 million for the same period in the prior year. The increase in general and administrative expenses for the nine months ended December 31, 2016 was primarily due to the following: a $888,000 increase in payroll expenses related to increased stock compensation expense and additional expenses related to the move of the corporate headquarters; a $168,000 increase in bank service fees; a $125,000 increase in bad debt expenses; a $26,000 increase in professional fees; and a $25,000 increase in telephone expenses. Offsetting the increase was a decrease to property expenses of $113,000; a $70,000 decrease to insurance expenses; and a $7,000 net decrease to other expenses which primarily included licenses and travel expenses.

### Advertising expenses

Advertising expenses decreased by approximately $818,000, or 21%, to approximately $3.2 million for the quarter ended December 31, 2016, from approximately $4.0 million for the quarter ended December 31, 2015. For the nine months ended December 31, 2016, advertising expenses decreased by approximately $4.8 million, or 27%, to approximately $13.3 million compared to advertising expenses of approximately $18.1 million for the nine months ended December 31, 2015. The decreases in advertising expenses for the three and nine months ended December 31, 2016 are mainly attributed to the elimination of television advertising spending. The advertising costs of acquiring a new customer, defined as total advertising costs divided by new customers acquired, decreased to $32 for the quarter ended December 31, 2016, compared to $41 for the quarter ended December 31, 2015. For the nine months ended December 31, 2016 and 2015, the advertising costs of acquiring a new customer were $34 and $49, respectively. The decreases in customer acquisition costs for the quarter and nine months can be attributed to increased sales conversion. Advertising cost of acquiring a new customer can be impacted by the advertising environment, the effectiveness of our advertising creative, advertising spending, and price competition. Historically, the advertising environment fluctuates due to supply and demand. A more favorable advertising environment may positively impact future new order sales, whereas a less favorable advertising environment may negatively impact future new order sales.

As a percentage of sales, advertising expense was 6.0% and 7.8% for the quarters ended December 31, 2016 and 2015, respectively, and for the nine months ended December 31, 2016 and 2015 advertising expense was 7.2% and 10.1%, respectively. The decreases in advertising expense as a percentage of total sales for the quarter and nine months ended December 31, 2016 can be attributed to the elimination of television advertising spending. The Company currently anticipates advertising as a percentage of sales to be approximately 7.0% for Fiscal 2017. However, the advertising percentage will fluctuate quarter to quarter due to seasonality and advertising availability. For the fiscal year ended March 31, 2016, quarterly advertising expenses as a percentage of sales ranged between 7.0% and 11.0%.

### Depreciation

Depreciation expense increased by approximately $290,000 to approximately $457,000 for the quarter ended December 31, 2016, compared to $167,000 for the quarter ended December 31, 2015. For the nine months ended December 31, 2016, depreciation expense increased by approximately $311,000 to approximately $855,000, compared to $544,000 for the same period in the prior year. The increases to depreciation expense for the quarter and nine months ended December 31, 2016 can be attributed to new property and equipment placed in service for the Company’s new corporate headquarters and distribution facility.

### Other income

Other income increased by approximately $115,000 to approximately $166,000 for the quarter ended December 31, 2016 from approximately $51,000 for the quarter ended December 31, 2015. For the nine months ended December 31, 2016, other income increased by approximately $154,000 to approximately $302,000 compared to approximately $148,000 for the same period in the prior year. The increase to other income for the quarter and nine months ended December 31, 2016 is related to advertising and rental revenue, offset by decreased interest income. Interest income may decrease in the future as the Company utilizes its cash balances on its share repurchase plan, with approximately $10.2 million remaining as of December 31, 2016, on any quarterly dividend payment, or on its operating activities.

### Provision for income taxes

For the quarters ended December 31, 2016 and 2015, the Company recorded an income tax provision of approximately $3.0 million and $2.8 million, respectively, and for the nine months ended December 31, 2016 and 2015, the Company recorded an income tax provision of approximately $9.8 million and $8.8 million, respectively. The increase to the income tax provision for the quarter and nine months ending December 31, 2016, is attributed to an increase in operating income, and a one-time charge of $96,000 related to a Fiscal 2016 income tax under-accrual, which was recognized in the quarter ended December 31, 2016. The effective tax rate for the quarters ended December 31, 2016 and 2015 was approximately 38.3% and 36.3%, respectively, and for the nine months ended December 31, 2016 and 2015 was approximately 37.5% and 36.8%, respectively. The Company estimates its effective tax rate will be approximately 37.5% for Fiscal 2017.

### Liquidity and Capital Resources

The Company’s working capital at December 31, 2016 and March 31, 2016 was $59.8 million and $60.5 million, respectively. The slight decrease in working capital was primarily attributable to cash flow generated from operations offset by dividends paid and increased property and equipment additions. Net cash provided by operating activities was $31.6 million and $22.6 million for the nine months ended December 31, 2016 and 2015, respectively. This change can mainly be attributed to a greater decrease in the Company’s inventory balance for the nine months ended December 31, 2016, as compared to December 31, 2015. Net cash used in investing activities was $9.9 million and $227,000 for the nine months ended December 31, 2016 and 2015, respectively. This change can be mainly attributed to increased property and equipment additions for the Company’s new corporate headquarters and distribution facility during the nine months ended December 31, 2016. Net cash used in financing activities was $11.5 million for the nine months ended December 31, 2016, compared to $10.9 million for the same period in the prior year, which represented an increase in the dividend paid in the period.

As of December 31, 2016, the Company had approximately $10.2 million remaining under the Company’s share repurchase plan. Subsequent to December 31, 2016, on January 23, 2017 our Board of Directors declared a $0.19 per share dividend. The Board established a February 6, 2017 record date and a February 17, 2017 payment date. Depending on future market conditions the Company may utilize its cash and cash equivalents on the remaining balance of its current share repurchase plan, on dividends, or on its operating activities.

As of December 31, 2016, the Company had no outstanding lease commitments as the lease for our 65,300 square foot facility, expired December 31, 2016. We are not currently bound by any long or short term agreements for the purchase or lease of capital expenditures. To date we have paid for any needed additions to our capital equipment infrastructure from working capital funds and anticipate this being the case in the future. Presently, we have approximately $1.2 million forecasted for capital expenditures for the remainder of Fiscal 2017, which will be funded through cash from operations. The Company’s primary source of working capital is cash from operations. The Company presently has no need for alternative sources of working capital, and has no commitments or plans to obtain additional capital.

### Off-Balance Sheet Arrangements

The Company had no off-balance sheet arrangements as of December 31, 2016.

### Cautionary Statement Regarding Forward-Looking Information

Certain information in this Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You can identify these forward-looking statements by the words "believes," "intends," "expects," "may," "will," "should," "plans," "projects," "contemplates," "intends," "budgets," "predicts," "estimates," "anticipates," or similar expressions. These statements are based on our beliefs, as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties, and assumptions. Actual future results may differ significantly from the results discussed in the forward-looking statements. A reader, whether investing in our common stock or not, should not place undue reliance on these forward-looking statements, which apply only as of the date of this quarterly report. When used in this quarterly report on Form 10-Q, "PetMed Express," "1-800-PetMeds," "PetMeds," "PetMed," "PetMeds.com," "PetMed.com," "PetMed Express.com," "the Company," "we," "our," and "us" refers to PetMed Express, Inc. and our subsidiaries.

## Market risk

As filed, 1,529 characters.

Market risk generally represents the risk that losses may occur in the value of financial instruments as a result of movements in interest rates, foreign currency exchange rates, and commodity prices. Our financial instruments include cash and cash equivalents, accounts receivable, and accounts payable. The book values of cash equivalents, accounts receivable, and accounts payable are considered to be representative of fair value because of the short maturity of these instruments. Interest rates affect our return on excess cash and investments. As of December 31, 2016, we had $47.9 million in cash and cash equivalents, and a majority of our cash and cash equivalents and investments generate interest income based on prevailing interest rates. A significant change in interest rates would impact the amount of interest income generated from our excess cash and investments. It could also impact the market value of our investments. Our investments are subject to market risk, primarily interest rate and credit risk. Our investments are managed by a limited number of outside professional managers within investment guidelines set by our Board of Directors. Such guidelines include security type, credit quality, and maturity, and are intended to limit market risk by restricting our investments to high-quality debt instruments with both short and long term maturities. We do not hold any derivative financial instruments that could expose us to significant market risk. At December 31, 2016, we had no debt obligations.

## Controls and procedures

As filed, 1,365 characters.

The Company’s management, including our Chief Executive Officer and Chief Financial Officer, has conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15 promulgated under the Securities Exchange Act of 1934, as amended) as of the quarter ended December 31, 2016, the end of the period covered by this report (the "Evaluation Date"). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective such that the information relating to our Company, including our consolidated subsidiaries, required to be disclosed by the Company in reports that it files or submits under the Exchange Act: (1) is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission rules and forms, and (2) is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

There were no changes in our internal control over financial reporting during our most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 386 characters.

Our operations and financial results are subject to various risks and uncertainties that could adversely affect our business, financial condition, results of operations, and trading price of our common stock. Please refer to our Annual Report on Form 10-K for Fiscal Year 2016 for additional information concerning these and other uncertainties that could negatively impact the Company.

Filed Jan 31, 2017.
Source: SEC EDGAR, the filing index for accession 0001571049-17-000891. Last ingested by Listed: Nov 13, 2026, 14:26 ET. No prices; not investment advice.
